About this trial
The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants with lung disease around discharge from the neonatal intensive care unit to home. This study looks to evaluate implementation of the recommendations at Boston Children's Hospital and referring NICU's (Beth Israel Deaconess Medical Center and Brigham and Women's Hospital). Specifically, the research team will be looking at follow-up rates, healthcare utilization, and parental satisfaction/feedback with implementation of these guidelines.
Eligibility criteria
Qualifiers
Preterm infants born <32 weeks with at least mild BPD, defined as 28 days of respiratory support after birth.
Efforts will be made to include a mix of infants with mild, moderate, and severe BPD, including infants discharged on oxygen.
Disqualifiers
Discharge to a location other than home.
Infants with other congenital disease (cardiac, genetic, neurological) thought to contribute significantly to their respiratory disease.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Boston Children's Hospital
Lead sponsor
Beth Israel Deaconess Medical Center
Collaborator
Brigham and Women's Hospital
Collaborator